A Study to Investigate LYL845 in Adults With Solid Tumors

NCT05573035 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

39

Enrollment

INDUSTRY

Sponsor class

Stopped Pipeline Reprioritization

Conditions

Melanoma
Non-small Cell Lung Cancer
Colorectal Cancer

Interventions

BIOLOGICAL: LYL845

Sponsor

Lyell Immunopharma, Inc.